Balance Sheet Details - Schedule of Accrued Expenses (Details) - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Accrued Liabilities, Current [Abstract]
Clinical studies	$ 2,156	$ 1,518
Other research and development	30,759	7,446
Acquired manufacturing rights	25,000	5,000
Other accrued expenses	1,900	1,411
Total	$ 59,815	$ 15,375